<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="PBCA-DE_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002127">
		<TITLE>ICGC PCAWG Dataset: PBCA-DE_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: PBCA-DE.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001223508"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223624"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223708"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223435"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223747"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223726"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223510"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223596"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223778"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225487"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225407"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225404"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225409"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223617"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223444"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223594"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223600"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223713"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223620"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223700"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223678"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225381"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225390"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225378"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223672"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223575"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223486"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225450"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225417"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225480"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223546"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223492"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223709"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223598"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223636"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223470"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225489"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225477"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225382"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223719"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223619"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223691"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225465"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225490"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223537"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223538"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223759"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225433"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223665"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223449"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223505"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223519"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223782"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225400"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225479"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225431"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225484"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223528"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223752"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223727"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223652"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223565"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225383"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223689"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225476"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223774"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223583"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223481"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225468"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223477"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223567"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223661"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223566"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223743"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223630"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225384"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223536"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223614"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223603"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223762"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223468"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225462"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223448"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223760"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225502"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223718"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223497"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223635"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223729"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223573"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223673"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223558"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225388"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223683"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223788"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223563"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223488"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225414"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223734"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223785"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223439"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223754"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223669"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225426"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225405"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225394"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225393"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225439"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223585"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223736"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225446"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223527"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223773"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225377"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225497"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223568"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223431"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223547"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225474"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225436"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223534"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223641"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223626"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223515"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223516"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223735"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223655"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223647"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223456"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223751"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223679"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223586"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225418"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223556"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223511"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223663"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223551"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225419"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225441"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225438"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225406"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223767"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223618"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225452"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225488"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223554"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223688"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223780"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223698"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225380"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223501"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223653"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223479"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225420"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223572"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225494"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223744"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225457"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223723"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225491"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223632"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223680"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223601"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223459"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225500"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223544"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223750"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223430"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225401"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223517"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223646"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223559"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225470"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223437"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223460"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225427"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223716"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223674"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223692"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223495"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225408"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223539"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225367"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225416"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223732"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225395"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225428"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225386"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223531"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223521"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225466"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225385"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225372"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223580"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225501"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225421"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223507"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225435"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225425"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225397"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223582"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223703"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223699"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225454"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225442"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223500"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225447"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223426"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223697"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223590"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223643"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225451"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225496"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223627"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225430"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225412"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223621"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223776"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223724"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223766"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223777"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223604"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223589"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225369"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225371"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223622"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225379"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223591"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223657"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223625"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223633"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223784"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223579"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223553"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223608"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225440"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223574"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223666"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225370"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223532"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223436"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223612"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225415"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223721"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223552"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223668"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223738"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223490"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225485"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223473"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225368"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223525"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223611"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225464"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223739"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223761"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223675"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223610"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223730"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223478"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223707"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223518"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225467"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225434"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223502"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223480"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225398"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223458"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223710"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223506"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223644"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223605"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223447"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225461"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225499"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223543"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225504"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225392"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223464"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223427"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223541"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223441"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225492"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223706"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223469"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223607"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223686"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223429"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225493"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225387"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223461"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223637"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223446"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225411"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223770"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225389"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223545"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223475"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223781"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223463"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223576"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223453"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223466"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223648"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223588"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223615"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225424"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223779"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223465"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225429"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223763"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223451"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225482"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223731"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223445"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225478"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223535"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223687"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225460"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225399"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223645"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223440"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225455"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223522"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223450"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223662"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223483"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223557"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223542"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225456"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223671"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225453"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223639"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223503"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225391"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223432"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225396"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223599"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223584"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223702"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225463"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223656"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223631"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223651"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223561"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223649"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223560"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223616"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223592"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223728"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223772"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225448"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223487"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223748"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223642"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223623"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223768"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225376"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223660"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223769"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223629"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223472"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225374"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223523"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223438"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223593"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223452"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223474"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223694"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223613"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223654"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223606"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223530"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223658"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223676"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225375"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223659"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223740"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223741"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223609"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223498"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223684"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223720"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225498"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225472"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223786"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225483"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223555"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223467"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223597"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223640"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223670"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225443"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223442"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225449"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223725"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223717"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223485"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223746"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223753"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223493"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223548"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223682"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223520"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223504"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223540"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223577"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223524"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223433"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223549"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223550"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223667"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223704"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225413"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223712"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223476"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225459"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223494"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223771"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223526"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225495"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225432"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225373"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223496"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225458"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223455"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223696"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223701"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223749"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223783"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225403"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225423"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223570"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223690"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225444"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223578"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223509"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223533"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225437"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223587"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223787"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223714"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223457"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223705"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223562"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223514"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223681"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225481"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223602"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223677"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223664"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223428"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223650"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223757"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223581"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223711"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223685"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223775"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223484"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223745"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223764"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223529"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223765"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223742"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223443"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225422"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223715"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223454"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223693"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225469"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223755"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223471"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225475"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223564"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223758"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225505"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223638"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223434"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223499"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223628"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223569"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223491"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223756"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225402"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223482"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223634"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223512"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225410"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225473"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223595"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223571"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223513"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223489"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223737"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225471"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223722"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>